Advanced Asset Management Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25
Closed -$2K 99
2020
Q4
$2K Buy
+25
New +$1.67K ﹤0.01% 97
2020
Q2
Sell
-74
Closed -$4K 115
2020
Q1
$4K Sell
74
-24
-24% -$1.46K ﹤0.01% 115
2019
Q4
$6K Buy
+98
New +$5.96K ﹤0.01% 119

Other funds holding PJP

Advanced Asset Management Advisors's PJP Position: Q1 2021 in Review

Advanced Asset Management Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2021, closing a stake of 25 shares — an estimated $2K sold.

Advanced Asset Management Advisors first reported a position in PJP in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 89 funds tracked by Wall St. Rank hold PJP as of Q1 2021.

  • Advanced Asset Management Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 25 Invesco Pharmaceuticals ETF shares in Q1 2021, an estimated $2K.
  • Advanced Asset Management Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and held it in 3 quarters.
  • Advanced Asset Management Advisors's Invesco Pharmaceuticals ETF position peaked at $6K in Q4 2019.
  • 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2021.

Based on Advanced Asset Management Advisors's 13F filing for Q1 2021, filed 3 May 2021.